Actively hiring
Patient Access & Booking
Clinical Trial Sites & Recruitment
As featured in
View 3 jobs
Claim pageClaim
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Total raised
$46.9M
4 rounds on record
Latest round
$29M
Venture round · Nov 2025 · 11 mo ago
Team
51-200
employees, estimated range
Hiring now
5
+2 posted in 30 days
Backers
1
Balderton Capital
The money's age
Fresh money
11 months since the last round · and hiring
Momentum
61/100
hiring for its size, a new city, in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 11, 2025
Raised a round Venture round $29M · YahooFinance
May 28, 2025
Launched myTomorrows unveils new SaaS platform to streamline global expanded access programs · Discover Pharma
Apr 15, 2025
Partnership myTomorrows and Scout Clinical Partner to Provide Cross-Border Patient Recruitment for Clinical Trials · PRNewswire
Feb 7, 2025
Launched myTomorrows Launches the AI Platform for Precision Trials · AIT365
Dec 5, 2024
Expanded myTomorrows expands into APAC to Improve access to Clinical Trials and Programs across the region · biospectrumasia.com
Aug 27, 2024
Partnership MyTomorrows partners with pancreatic cancer pressure group to drive trials · YahooFinance
Dec 6, 2023
Launched myTomorrows Unveils New Patient Engagement Tactics with AI · The Clinical Trial Vanguard - Your premier source for the latest clinical trial news
Apr 25, 2023
Launched myTomorrows releases advanced AI search tool for physicians to identify trials · Clinical Trials Arena
Dec 18, 2019
Partnership myTomorrows and Omeros Corporation Collaborate to Provide an Expanded Access Program for Narsoplimab · Nasdaq
Jan 9, 2017
Raised a round Venture round $10.8M · TechCrunch
Nov 7, 2014
Raised a round Venture round $4.9M · TechCrunch
Feb 19, 2014
Raised a round Venture round $2.2M · TechCrunch
2012
Founded
Tractionpublic signals, read monthly
Web presence
top 0.43%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Nov 2025 | $29M | — | YahooFinance |
| Venture round | Jan 2017 | $10.8M | — | TechCrunch |
| Venture round | Nov 2014 | $4.9M | — | TechCrunch |
| Venture round | Feb 2014 | $2.2M | — | TechCrunch |
Registers and programsofficial lists and records that name the company
| Legal entity | Impatients N.V. | its site |
Founders and leadersfrom filings, registers and the company's site
Regulatory AffairsDirectorcompany's site
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Find clinical trials that match your condition quickly with MyTrials.ai. Our AI-driven platform helps patients access breakthrough…

FindMeCure is the Google for Clinical Trials. We help you find, weigh and understand treatments in development.

Research Grid (R.grid) automates the entire clinical trial back-office by accelerating timelines and cutting admin delays. Get faster and…

AI platform connecting patients to clinical trials. Activate providers, identify eligible patients, and navigate them through trials across…

HealthMatch connects motivated patients to clinical trials and delivers EMR-verified, site-ready referrals to trial sites and sponsors.

TrialeX revolutionises clinical trial recruitment and retention. An accessible, easy-to-use platform. Get rewarded for engaging with and…
Visa sponsorship
- Netherlands · Recognised sponsor of the Dutch immigration service (IND)
News
How to Enhance DEI in Clinical Trials PharmExec
Integrating DEI strategies into clinical trials is both crucial for advancing biomedical knowledge and for bolstering trust and equitability within underrepresented communities.
Read more
Report
Ready, willing and prepared: living with LGMD2i and navigating clinical trials
In June 2026, I met Marg online to talk about her experience of living with a rare condition, and in particular about searching for and accessing clinical trials. Marg lives in Canada and has spent more than 20 years learning about LGMD2i, the muscle-weak
Read more
Report
Your Recruitment Plan Is Failing Before Screening Even Starts
59% of sites report recruitment blocked by process inefficiencies-the bottleneck isn't patient supply, it's the workflow that never gets fixed before FPI.
Read more
Report
myTomorrows: Interview With CEO Dr. Michel van Harten About Clinical Trials, Expanded Access, And The Future Of Health Tech
myTomorrows is a global health technology company that helps patients and physicians navigate and access pre-approval treatments, such as clinical trials and expanded access programs. Pulse 2.0 interviewed myTomorrows CEO Dr. Michel van Harten to learn mo
Read more
Report
Why Clinical Trials Rely on Caregivers
Finding the right clinical trial takes time, but caregivers can make participation possible through coordination and ongoing support
Read more
Report
Prescribing Change: Improving AI Adoption Among Physicians
While physicians recognize AI's potential, significant barriers remain-from data privacy and liability concerns to the need for practical training.
Read more
Report
AWS Pioneers 2026: Europe's most impactful AI startups
AWS has named its 2026 European Pioneers cohort: 12 AI companies tackling leukaemia, ocean mapping, conflict early warning, and drug discovery.
Read more
Report
Empowered Patient Podcast: AI Platform Facilitating Improved Accessibility to Clinical Trials with Vanessa Lemarié myTomorrows
Vanessa Lemarié, Chief Operations Officer at myTomorrows, which is a platform for connecting patients, physicians, and clinical trial sponsors using a Trial Search AI tool designed to improve the accuracy of matching patients with suitable trials. The tec
Read more
Report
myTomorrows; Zydus: Sentynl Selects myTomorrows to Lead Managed Access Program
Reinforcing its commitment to rare disease treatment access, Sentynl is transitioning its program to myTomorrows patient-centric platform. AMSTERDAM, Dec. 10, 2025 /PRNewswire/ -- Sentynl Therapeutics
Read more
Report
Show more news
Tech stack
Technologies named in job postings at myTomorrows over the last 12 months, by layer, with the share of postings for each.
Technologies in use
48
Postings analysed
12
Stack modernity
77/100AI adopter
Languages
Python58%
JavaScript50%
TypeScript50%
PHP33%
Frameworks & libraries
FastAPI50%
Angular50%
Pydantic42%
SQLAlchemy42%
Databases
MySQL50%
Neo4j50%
PostgreSQL50%
DynamoDB33%
Cloud & platforms
GCP50%
AWS50%
GitHub Actions50%
Kubernetes50%
AI & ML
LLM17%
Sign in to see how your skills match this stack
Sign In
Full myTomorrows tech stack
48 technologies · by team · pay by technology · changes · similar stacks
People

Regulatory Affairs
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
71/100
Growing
Open positions
5
3 opened / 4 closed in 30 days
Median time-to-fill
32 days
faster than 39% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
HR
47% ▲
Backend
33% ▼
Data Science
7% ▲
Security
7% ▼
Analytics
7% ▼
Activity Timeline
New location: Canada
Oct 2026
New location: United Kingdom
Oct 2026
New location: United States
Oct 2026
Added Rest API to stack
Sep 2026
Added Microsoft Excel to stack
Sep 2026
Added Machine Learning to stack
Sep 2026
Added Microsoft Office to stack
Sep 2026
Added Smartsheet to stack
Sep 2026
Added Tableau to stack
Sep 2026
Added NumPy to stack
Sep 2026
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Amsterdam
Amsterdam
Netherlands
HQ
5 open roles 14 posted in 90 days 60% engineering 50-200 est. staff
hires for Backend, HR
Jobs
≈ $49k – $107k per year (Estimated) • Equity • Hybrid • Full-Time • 3+ years exp • Amsterdam
Python
JavaScript
PHP
TypeScript
SQLAlchemy
FastAPI
Pydantic
pre-commit
PHP
WordPress
Databases
MySQL
PostgreSQL
Neo4j
AI/ML
Cursor
Claude Code
LLM
OpenAI
Anthropic
Knowledge Graph
Frontend
Angular
Lit
DevOps
Rest API
Terraform
GitHub Actions
AWS
Docker
Kubernetes
SLI/SLO/SLA
Apply
≈ $49k – $106k per year (Estimated) • Equity • Hybrid • Full-Time • 3+ years exp • Amsterdam
Python
JavaScript
PHP
TypeScript
SQLAlchemy
FastAPI
Poetry
Pydantic
pre-commit
PHP
WordPress
Databases
MySQL
PostgreSQL
Neo4j
Oracle
DynamoDB
AI/ML
Knowledge Graph
Frontend
Angular
DevOps
Terraform
GCP
Docker Compose
GitHub Actions
CloudFormation
Azure
CI/CD
AWS
Docker
Kubernetes
AWS Lambda
SLI/SLO/SLA
Cybersecurity
Least Privilege
Renovate
Apply
≈ $61k – $105k per year (Estimated) • Equity • Hybrid • Full-Time • 4+ years exp • Amsterdam
Python
JavaScript
TypeScript
SQLAlchemy
FastAPI
Ruff
Pydantic
Databases
MySQL
PostgreSQL
Neo4j
Oracle
DynamoDB
AI/ML
Knowledge Graph
Frontend
Angular
DevOps
GCP
Docker Compose
GitHub Actions
Azure
CI/CD
AWS
Docker
Kubernetes
SLI/SLO/SLA
Cybersecurity
Least Privilege
Renovate
Apply

Balderton Capital 




